You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Bioactuator-Driven Ankle Dorsiflexor Unit
SBC: ADA TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): A significant number of individuals in the U.S. are affected by diseases and injuries that give rise to a troublesome condition called foot drop. Diabetes mellitus, dysvascular diseases, peripheral neuropathies, and other conditions render some individuals unable to lift their foot effectively during their gait cycle, leaving them susceptible to falling or inju ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
A Biocatalytic Route to Nitrile Reduction
SBC: QUZYME, LLC Topic: N/ADESCRIPTION (provided by applicant): The recently identified ykvM gene family encodes an enzyme belonging to a unique family of nitrile oxido-reductases that catalyze the reduction of 7-cyano-7-deazaguanine to 7-aminomethyl-7-deazaguanine, a transformation never before observed in biology. Nitrile containing compounds are ubiquitous in the pharmaceutical, agricultural, and chemical industries, wh ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
A BIODEGRADABLE, INJECTABLE DELIVERY SYSTEM FOR NSAIDS
SBC: ATRIX LABORATORIES, INC. Topic: N/AIN THIS RESEARCH, NSAIDS WILL BE INDIVIDUALLY INCORPORATED INTO A DELIVERY SYSTEM. THE IN VITRO DELIVERY RATES WILL BEDETERMINED, AND THEN THE SYSTEM OPTIMIZED TO OBTAIN IN VITRO DELIVERY RATES OF 1 TO 12 WEEKS. THE VARIABLES THAT WILL BE EXAMINED TO OPTIMIZE RELEASE ARE POLYMER TYPE AND MOLECULAR WEIGHT, DRUG LOADING, AND BIOCOMPATIBLE PLASTICIZER CONTENT. FIVE NSAIDS WILL BE INDIVIDUALLY EVALUAT ...
SBIR Phase I 1990 Department of Health and Human Services -
A BIODEGRADABLE WOUND TREATMENT
SBC: ATRIX LABORATORIES, INC. Topic: N/AWE WILL DEVELOP A BIODEGRADABLE WOUND TREATMENT THAT CAN BE AEROSOLIZED DIRECTLY ONTO A WOUND SURFACE. IT WILL FORM A TOUGH, FLEXIBLE FILM THAT WILL SEAL THE WOUND AND PROVIDE FOR PROPER WATER LEVELS AT THE WOUND SURFACE. AN ANTIBIOTIC WILL BE INCORPORATED INTO THE BIODEGRADABLE POLYMER AND WILL BE SLOWLY RELEASED INTO THE WOUND BOTH TO ELIMINATE EXISTING INFECTION AND TO PREVENT LATER INFECTION. ...
SBIR Phase I 1991 Department of Health and Human Services -
A Biomimetic Prehensile Digit for Upper-Limb Amputees
SBC: Invisible Hand Enterprises, LLC Topic: NICHDDESCRIPTION provided by applicant Prostheses reduce the incidence of contralateral overuse syndrome in upper limb amputees by encouraging balanced bimanual limb usage Benefits include reduced pain and muscular atrophy increased productivity and self reliance improved self image a sense of well being and increased social acceptance Body powered prostheses are used extensively in the Uni ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A Biomimetic Prehensile Digit for Upper-Limb Prostheses
SBC: Invisible Hand Enterprises, LLC Topic: NICHDDESCRIPTION (provided by applicant): Among amputation types involving the upper limbs, partial hand is the most prevalent by far and among the most challenging for prosthetists to address well. Sound side overreliance for these amputees gives rise to a high prevalence of contralateral overuse syndrome (COS), a progressive, painful, and debilitating condition. Research shows that prostheses reduce ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
A Broadly Accessible Virtual Reading Tutor
SBC: MENTOR INTERACTIVE, INC. Topic: N/ADESCRIPTION (provided by applicant): Millions of children in the U.S. are at risk for learning to read well despite major advances in our understanding of the causes and cures for poor reading. In this Fast- Track proposal we propose to address this signif icant need and opportunity with a computer-based reading program that combines the power of one-on-one tutoring with the benefits of self-asses ...
SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health -
A Broadly Accessible Virtual Reading Tutor
SBC: MENTOR INTERACTIVE, INC. Topic: N/ADESCRIPTION (provided by applicant): Millions of children in the U.S. are at risk for learning to read well despite major advances in our understanding of the causes and cures for poor reading. In this Fast- Track proposal we propose to address this significant need and opportunity with a computer-based reading program that combines the power of one-on-one tutoring with the benefits of self-assess ...
SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health -
A Catalytic Filter System for Indoor Air Quality Improvement
SBC: TDA RESEARCH, INC. Topic: RProject Abstract According to the EPA, indoor levels of pollutants are often 2-5 times and up to 100 times higher than outdoor levels and people spend ~90% of their time indoors. The combination of energy saving methods such as tightly sealed buildings and reduced ventilation rates combined with increased use of synthetic building materials and furnishings, personal care products, pesticides, hous ...
SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Acceleration of heart failure in the SHHF rat model
SBC: MYOGEN, INC. Topic: N/ADESCRIPTION (provided by applicant): Myogen's goal is to discover novel disease-modifying therapies for heart failure (HF). Approximately 700,000 individuals are affected each year by HF, which is a common endpoint of many cardiovascular diseases. The annual health care costs for HF patients in the United States is estimated at $10-40 billion. Clearly, novel treatment approaches are necessary. Ani ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health